Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Seagen - What’s next for ADCs in oncology?

State of the art and perspectives

Date

01 Dec 2023

Session

Seagen - What’s next for ADCs in oncology?

Presenters

Solange Peters

Authors

S. Peters

Author affiliations

Oncology Dept., CHUV - Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

01 Dec 2023

Welcome and introduction

Presenter: Solange Peters

Session: Seagen - What’s next for ADCs in oncology?

Resources:

Webcast

01 Dec 2023

Advances in integrin targeting

Presenter: Kenneth O'Byrne

Session: Seagen - What’s next for ADCs in oncology?

Resources:

Webcast

01 Dec 2023

Multimodal immune targeting with ADCs

Presenter: Emiliano Calvo

Session: Seagen - What’s next for ADCs in oncology?

Resources:

Webcast

01 Dec 2023

Panel discussion, live Q&A, and conclusions

Presenter: All Speakers

Session: Seagen - What’s next for ADCs in oncology?

Resources:

Webcast